FDANonrulemakingFDA-2026-D-4272
Who commented on this docket
Biosimilar and Interchangeable Biosimilar Products: Considerations for Container Closure Systems and Device Constituent Parts; Draft Guidance for Industry; Availability
4 organizations filed 4 public comments on Biosimilar and Interchangeable Biosimilar Products: Considerations for Container Closure Systems and Device Constituent Parts; Draft Guidance for Industry; Availability, at the Food and Drug Administration.
Organizations
4
Comments
4
RIN
—
Comment window
—
Commenters (4)
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- Association for Accessible Medicinestrade assoc.1 filing · confidence 97%
- Chong Kun Dang Pharmaceuticals Corp.unverified attribution1 filing · confidence 70%
- Combination Products Coalitiontrade assoc.1 filing · confidence 85%
Attribution is name-based and imperfect. regulations.gov data is public record.